The Traderszone Network

Published in TZ Latest News 7 June, 2015 by The TZ Newswire Staff

A Big Step for This Tiny Biotech That’s Targeting Rare Diseases

Amicus Therapeutics, Inc. has filed for European approval for its Fabry disease drug Galafold.